Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 2
1966 1
1969 3
1970 1
1971 4
1972 3
1973 2
1974 3
1975 2
1976 4
1977 4
1978 5
1979 3
1980 2
1981 5
1982 3
1983 3
1984 6
1985 9
1986 7
1987 8
1988 6
1989 13
1990 8
1991 11
1992 11
1993 14
1994 10
1995 14
1996 8
1997 16
1998 10
1999 8
2000 11
2001 4
2002 6
2003 11
2004 8
2005 5
2006 6
2007 3
2008 6
2009 7
2010 3
2011 7
2012 8
2013 7
2014 5
2015 6
2016 1
2017 4
2018 7
2019 8
2020 13
2021 10
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

338 results
Results by year
Filters applied: . Clear all
Page 1
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.
Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne MC, Horton HF, Fouser L, Carter L, Ling V, Bowman MR, Carreno BM, Collins M, Wood CR, Honjo T. Freeman GJ, et al. Among authors: ling v. J Exp Med. 2000 Oct 2;192(7):1027-34. doi: 10.1084/jem.192.7.1027. J Exp Med. 2000. PMID: 11015443 Free PMC article.
Stem cell gene expression programs influence clinical outcome in human leukemia.
Eppert K, Takenaka K, Lechman ER, Waldron L, Nilsson B, van Galen P, Metzeler KH, Poeppl A, Ling V, Beyene J, Canty AJ, Danska JS, Bohlander SK, Buske C, Minden MD, Golub TR, Jurisica I, Ebert BL, Dick JE. Eppert K, et al. Among authors: ling v. Nat Med. 2011 Aug 28;17(9):1086-93. doi: 10.1038/nm.2415. Nat Med. 2011. PMID: 21873988
Primate archaeology.
Haslam M, Hernandez-Aguilar A, Ling V, Carvalho S, de la Torre I, DeStefano A, Du A, Hardy B, Harris J, Marchant L, Matsuzawa T, McGrew W, Mercader J, Mora R, Petraglia M, Roche H, Visalberghi E, Warren R. Haslam M, et al. Among authors: ling v. Nature. 2009 Jul 16;460(7253):339-44. doi: 10.1038/nature08188. Nature. 2009. PMID: 19606139 Review.
Multidrug resistance.
Ling V, Gerlach J, Kartner N. Ling V, et al. Breast Cancer Res Treat. 1984;4(2):89-94. doi: 10.1007/BF01806390. Breast Cancer Res Treat. 1984. PMID: 6146362 Review.
Wellness programs.
Tjoa A, Ling V, Bender C, Brittenham M, Jha S. Tjoa A, et al. Among authors: ling v. J Am Coll Radiol. 2012 Dec;9(12):894-9. doi: 10.1016/j.jacr.2012.09.011. J Am Coll Radiol. 2012. PMID: 23206647
Mechanism of multidrug resistance.
Bradley G, Juranka PF, Ling V. Bradley G, et al. Among authors: ling v. Biochim Biophys Acta. 1988 Aug 3;948(1):87-128. doi: 10.1016/0304-419x(88)90006-6. Biochim Biophys Acta. 1988. PMID: 2899442 Review. No abstract available.
Multidrug resistance in cancer.
Kartner N, Ling V. Kartner N, et al. Among authors: ling v. Sci Am. 1989 Mar;260(3):44-51. doi: 10.1038/scientificamerican0389-44. Sci Am. 1989. PMID: 2564696 Review.
The protective role of hydrophilic tetrahydroxylated bile acids (THBA).
Sheps JA, Wang R, Wang J, Ling V. Sheps JA, et al. Among authors: ling v. Biochim Biophys Acta Mol Cell Biol Lipids. 2021 Jul;1866(7):158925. doi: 10.1016/j.bbalip.2021.158925. Epub 2021 Mar 11. Biochim Biophys Acta Mol Cell Biol Lipids. 2021. PMID: 33713832 Review.
Multidrug resistance in leukemia.
Rischin D, Ling V. Rischin D, et al. Among authors: ling v. Cancer Treat Res. 1993;64:269-93. doi: 10.1007/978-1-4615-3086-2_13. Cancer Treat Res. 1993. PMID: 8095795 Review. No abstract available.
338 results